Login
Products
Login
Home
Alerts
Search
Watchlist
Products

KMC Speciality Hospitals (India) Ltd

KMCSHIL
BSE
87.70
0.15%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

KMC Speciality Hospitals (India) Ltd

KMCSHIL
BSE
87.70
0.15%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
1,430Cr
Close
Close Price
87.70
Industry
Industry
Hospitals
PE
Price To Earnings
39.33
PS
Price To Sales
5.03
Revenue
Revenue
284Cr
Rev Gr TTM
Revenue Growth TTM
31.96%
PAT Gr TTM
PAT Growth TTM
52.69%
Peer Comparison
How does KMCSHIL stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
KMCSHIL
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
414142494553566161677582
Growth YoY
Revenue Growth YoY%
26.016.56.922.79.329.932.924.935.725.433.233.7
Expenses
ExpensesCr
303131353340444546505457
Operating Profit
Operating ProfitCr
111011141213131615162125
OPM
OPM%
27.424.726.329.326.324.422.326.125.324.727.830.2
Other Income
Other IncomeCr
121111011111
Interest Expense
Interest ExpenseCr
000012322222
Depreciation
DepreciationCr
222234555555
PBT
PBTCr
109912975109101518
Tax
TaxCr
222322134245
PAT
PATCr
77797648581114
Growth YoY
PAT Growth YoY%
70.413.6-2.050.4-2.3-20.6-43.5-20.9-36.336.8179.482.8
NPM
NPM%
17.717.016.219.315.810.46.912.27.411.314.516.7
EPS
EPS
0.50.40.40.60.40.30.20.50.30.50.70.8

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
364355718296103136156177232284
Growth
Revenue Growth%
13.817.328.828.916.416.96.732.614.513.830.722.8
Expenses
ExpensesCr
3135435766757999114130175207
Operating Profit
Operating ProfitCr
6812141621233741475777
OPM
OPM%
15.518.622.420.019.421.922.627.326.526.824.627.2
Other Income
Other IncomeCr
010021223434
Interest Expense
Interest ExpenseCr
221111111199
Depreciation
DepreciationCr
43344567891921
PBT
PBTCr
048101217183236413252
Tax
TaxCr
013345589101015
PAT
PATCr
0357912132427302137
Growth
PAT Growth%
141.92,493.866.624.229.436.48.885.712.513.8-29.571.0
NPM
NPM%
0.37.59.89.410.512.212.417.417.117.19.312.9
EPS
EPS
0.00.20.30.40.50.70.81.41.61.91.32.2

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
161616161616161616161616
Reserves
ReservesCr
-6-38142334477097127148166
Current Liabilities
Current LiabilitiesCr
91010121212132023463837
Non Current Liabilities
Non Current LiabilitiesCr
12641187292246748481
Total Liabilities
Total LiabilitiesCr
312938536070105129182264286300
Current Assets
Current AssetsCr
33481318264252343350
Non Current Assets
Non Current AssetsCr
2827344547527986130230253250
Total Assets
Total AssetsCr
312938536070105129182264286300

Cash Flow

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
56101216112629323858
Investing Cash Flow
Investing Cash FlowCr
-1-1-4-19-9-8-43-29-48-56-51
Financing Cash Flow
Financing Cash FlowCr
-5-5-56-5-418-11621-2
Net Cash Flow
Net Cash FlowCr
001-11-110034
Free Cash Flow
Free Cash FlowCr
556-3137-1516-12-37-6
CFO To PAT
CFO To PAT%
4,381.6178.4187.8186.5183.991.1200.3122.7121.1126.5268.7
CFO To EBITDA
CFO To EBITDA%
96.472.581.787.899.050.7110.278.378.281.1101.2

Ratios

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
461292122932522043569089381,3241,001
Price To Earnings
Price To Earnings
285.039.439.443.829.117.427.938.435.143.646.9
Price To Sales
Price To Sales
1.33.03.94.13.12.13.56.76.07.54.3
Price To Book
Price To Book
4.69.68.89.76.44.05.610.58.39.26.1
EV To EBITDA
EV To EBITDA
10.117.117.521.315.89.515.824.323.029.219.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
82.483.583.985.285.585.784.184.985.386.285.5
OPM
OPM%
15.518.622.420.019.421.922.627.326.526.824.6
NPM
NPM%
0.37.59.89.410.512.212.417.417.117.19.3
ROCE
ROCE%
9.927.133.625.428.830.620.628.422.518.516.2
ROE
ROE%
1.224.022.321.922.023.220.227.323.521.213.0
ROA
ROA%
0.410.914.112.614.516.812.218.414.711.57.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
KMC Speciality Hospitals (India) Limited, a subsidiary of **Sri Kauvery Medical Care (India) Limited** (which holds a **75%** stake), is a premier tertiary healthcare provider headquartered in Trichy, Tamil Nadu. Operating under the renowned **Kauvery Hospital** brand, the company specializes in high-end multi-specialty services, organ transplants, and advanced mother and child care. --- ### **Strategic Infrastructure and Capacity Expansion** The company has aggressively expanded its footprint in the Trichy region, transitioning from a single-unit hospital to a dual-facility powerhouse with a combined capacity of **450 beds**. | Facility | Focus Area | Capacity | Status | | :--- | :--- | :--- | :--- | | **Legacy Block** (Main Unit) | Multi-Specialty Tertiary Care | **250 Beds** | Operational (G+6F+1B) | | **Maa Kauvery** (New Unit) | Mother & Child; Paediatric Super Specialties | **200 Beds** | Operational since **Jan 29, 2024** | **Maa Kauvery Unit Highlights:** * **Specialized Intensive Care:** Features a **50-bedded** Neonatal Intensive Care Unit (**NICU**), a **16-bedded** Paediatric Intensive Care Unit (**PICU**), and an **11-bedded** Paediatric Emergency Department. * **Transplant Excellence:** Includes a dedicated **5-bedded** unit for Bone Marrow, Liver, and Renal transplants. * **Diagnostic Suite:** Equipped with **CT, MRI, Mammogram, Dexa Scan**, and advanced **OT Theatres** (including Labour OT). --- ### **Operational Model and Regional Dominance** The company operates in a single segment—**Medical and Healthcare Services**—with a dominant market share in Central Tamil Nadu. * **Catchment Area:** Approximately **92%** of In-patients are drawn from **9 key districts**, with a service radius extending over **200 kilometers**. * **Patient Volume (FY24):** Recorded **14,194** In-patient and **1,24,318** Out-patient visits. * **Occupancy Levels:** Maintained a high average occupancy rate of **over 90%** (FY24). * **Strategic Outsourcing:** To optimize specialized care, cardiac procedures for government-empanelled patients are outsourced to **Kauvery Heart City Hospital** (a division of the holding company) located on the same premises. * **Human Capital:** Supported by a workforce of **1700+** employees and associates, including **170 Doctors**. **IP Volume Distribution by District:** * **Tiruchirapalli:** **50%** * **Pudukkottai & Thanjavur:** **9% each** * **Ariyalur & Perambalur:** **9% combined** * **Other Districts (Karur, Cuddalore, etc.):** **15%** --- ### **Digital Transformation and Clinical Integration** KMC leverages a "Digital First" approach to enhance patient safety and operational throughput. * **Clinical Automation:** Implementation of **Electronic Medical Records (EMR)** and **Electronic Prescriptions** to eliminate medication errors. * **Connected ICU:** A digital platform utilizing advanced sensors for **real-time monitoring** and immediate clinical intervention. * **Proprietary CRM (CHARM):** A unified initiative that integrates all patient interactions into a single platform for personalized communication. * **Administrative Efficiency:** Deployment of **Robotic Process Automation (RPA)**, including an automated **GRN system** processing **4,300 documents monthly**. --- ### **Financial Performance and Credit Profile** The company has demonstrated a robust growth trajectory, characterized by a **10-year Revenue CAGR of 17.8%** and a **10-year PBT CAGR of 38.6%**. **Key Financial Metrics:** | Metric (INR Lakhs) | FY 2024-25 | FY 2023-24 | FY 2022-23 | | :--- | :--- | :--- | :--- | | **Total Income** | **23,468.40** | **18,073.52** | **15,576.00** | | **EBITDA** | **5,997.18** | **5,094.57** | **4,450.23** | | **Networth** | **19,570.00** (Q3'26) | **14,357.97** | **11,350.21** | | **Debt-Equity Ratio** | - | **0.35** | **0.39** | **Recent Quarterly Highlights (Q3 FY'26):** * **Revenue Growth:** **33%** YoY increase. * **Margin Expansion:** EBITDA Margin improved to **31%** (up from **27%**); PAT Margin rose to **16.5%**. * **Liquidity:** Cash and fixed deposits stood at **INR 49.0 Cr** as of Dec 2025. **Credit Rating Upgrade (March 2026):** **India Ratings and Research (Ind-Ra)** upgraded the long-term rating to **IND AA- / Stable** (from IND A+), citing a strengthening financial profile and successful scaling of the Maa Kauvery unit. --- ### **Sustainability and ESG Framework** KMC is transitioning toward a green energy model to mitigate rising utility costs and environmental impact. * **Energy Transition:** Currently sources **78%** of energy from renewable sources (Solar/Wind). * **Strategic Investment:** Acquired a **26% stake** in **Gardenia Energy Private Limited** (Sept 2025) to secure solar power. * **Target:** Aiming for **100% renewable energy usage** by the end of **FY 2026-27**. * **Resource Efficiency:** 100% LED lighting, **BLDC fans** (60% power reduction), and **Variable Frequency Drives (VFD)** for HVAC systems. * **Waste Management:** Discontinued **one-time plastics**; hazardous and bio-medical waste are managed via government-approved vendors. --- ### **Academic and Talent Strategy** To counter the industry-wide scarcity of skilled medical resources, the company has pivoted toward an academic-led growth model. * **Medical Education:** Increased academic capacity from **20+** seats in 2024 to over **44 DnB and Diploma seats** by late 2025. * **Quality Standards:** **NABH accredited** and a pioneer in adopting the **5S Workplace Organization Method** in the Indian healthcare sector. --- ### **Risk Management and Governance** The company maintains a rigorous risk mitigation framework overseen by a dedicated committee. **Legal and Regulatory Exposures:** * **Supreme Court Compliance:** Remitted **Rs. 7.01 Cr** in Sept 2024 to settle a long-standing property auction litigation (V.S. Palanivel Case). * **Minimum Wage Litigation:** Currently protected by an **interim stay** against a Tamil Nadu government notification revising hospital wages; the final outcome remains a potential financial sensitivity. * **Corporate Guarantees:** Provides guarantees for its holding company up to **Rs. 98.57 Crs** (capped at **60% of Tangible Net Worth**). **Operational Risks:** * **Manpower Attrition:** High competition for specialized clinical talent. * **Cybersecurity:** Reported **Nil** data breaches for FY24/25; currently streamlining shareholder e-voting via a **single login credential** system through NSDL/CDSL. * **Safety:** Conducts fire drills **twice a year** and regular amenity risk audits to manage high-pressure systems like **O2 cylinders**.